Why INmune Bio Stock Soared Then Sank Today

Keith Speights, The Motley Fool
·2-min read
Why INmune Bio Stock Soared Then Sank Today

INmune's shares were sinking 17% as of 3:39 p.m. EST. The big jump came after the biotech announced encouraging results from a phase 1b study evaluating XPro1595 in treating Alzheimer's disease. It's not all that surprising to see such high volatility for a clinical-stage biotech stock.